Contact the Editorial Desk

Editorial correspondence

Peptide Ways welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference gone out of date, or a peer-reviewed study on DSIP or Selank that should be added to the references page. Corrections that improve the accuracy of the digest are the most useful messages we receive and are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the source directly.

Editorial mailbox: editors@peptideways.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, several things fall outside what this site can address. Peptide Ways is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of DSIP, Selank, or any other peptide.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or assess whether a particular research finding applies to a particular person's situation.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer requests from athletes subject to anti-doping rules about using these compounds — both sit under WADA's S0 non-approved-substances catch-all.

Readers seeking guidance on sleep or anxiety should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.